Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

Original Source : Colorectal Cancer Market

Buy Now: Market Research

Browse all : Pharmaceuticals Market

GlobalData, the industry analysis specialist, has released its new report, "Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010". The report is an essential source of information and analysis on the global colorectal cancer therapeutics market. The report provides comprehensive information on colorectal cancer, highlighting the treatment guidelines. It identifies and analyses the key trends shaping and driving the global colorectal cancer therapeutics market. It analyses the treatment usage patterns in the global colorectal cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. The report provides valuable insights into the pipeline products within the global colorectal cancer sector. It quantifies the unmet need in the global colorectal cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for future players.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The scope of the report includes:

An overview of colorectal cancer which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.

Annualized global colorectal cancer therapeutics market revenue, annual cost of therapy and treatment usage patterns data from 2001 to 2009, forecast for 11 years to 2020.

Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France Japan and BRIC countries that include Brazil, Russia, India and China

Insightful review of the key industry drivers, restraints and challenges and predicted impact of key events.

Competitor assessment including drug launch analysis and drug sales forecasts.

Product profiles covering efficiency, safety, clinical study details, annual cost, regulatory approvals, LCM activities, product positioning and drug sales forecast.

Analysis of unmet need in the market and target product profile including opportunity for target product.

Technology trends analytic framework to assess strength of pipeline.

Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include EGFR inhibitors, VEGF inhibitors, monoclonal antibodies, angiogenesis inhibitors and others.

An overview of the most promising drugs' including clinical study details, efficacy, safety, collaboration agreements, marketing rights, and launch analysis and drug sales forcasts to 2020.

Analysis of the current and future market competition in the US Colorectal Cancer therapeutics market. Company profiles including business description, financial overview and SWOT analysis. Key future market players covered include Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Eli Lilly, Sanofi-Aventis, Debiopharm Group and Merck KGaA.

Analysis of licensing agreements during 2004-2010 in the colorectal cancer therapeutics market. M&A analysis which includes M&A deals by size and geography.

Strategic assessment of the market through market impact analysis, future market scenario and company analysis.

Direct quotes from key opinion leaders (KOL) or physicians in the colorectal cancer therapeutics market in the US.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

Develop business strategies and perform superior market quantification analysis by

Understanding the trends shaping and driving the global colorectal cancer therapeutics market.

Understanding treatment preferences of physicians in disease state and across treatment flow.

Accessing market sizing, forecasts and quantified growth opportunities in the global colorectal cancer therapeutics market till 2020.

Quantifying patient population in the global colorectal cancer market to better design product pricing & launch plans.

Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape by

Performing benchmarking analysis and growth opportunities against currently marketed products

Identifying market entry points based on safety, efficacy, and pricing parameters.

Assessing competitiveness of products in market by understanding the strength and weakness of current competition.

Develop and design your in-licensing and out-licensing strategies by

Taking a comprehensive look of at the disease pipeline and identifying most promising paradigm shifting products.

Assessing strength of pipeline bases on first in class, me-too, generic and lifecycle management of products.

Track drug sales in the global colorectal cancer therapeutics market from 2001 to 2020

Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.

What's the next big thing in the global colorectal cancer therapeutics market landscape? Identify, understand and capitalize.

POST COMMENT

Globalization Impact on Accounting Education Validating Excel And Word Applications Documents - Webinar By Globalcompliancepanel How International Freight Shipping is Beneficial Global Warming is for Real. New Evidence point out Free Shipping: Good Or Bad? Medical Device Changes And The 510(k) - Webinar By Globalcompliancepanel Tata Motors global sales grow by 18 per cent Aarkstore Enterprise Report On Global Lfp (lifepo4) Industry, 2009 Products And Ingredients For Heart Health Consumer Groups 2009 - Health Issues, Global Trends, B2b A Root Cause Analysis: Shutting Down the Alligator Farm - Webinar By GlobalCompliancePanel Global Top 10 Drug Discovery Technologies Market to be $ 54 Billion by 2015 The Global Juice Report - 2010 West Europe --- Aarkstore Enterprise Why CCSVI in India Attracts Patients Globally